Summary
Elevance Health, Inc. (ELV), formerly WellPoint, Inc., reported robust performance in its 2008 Annual Report, demonstrating growth in total operating revenue to $61.6 billion, a 2% increase year-over-year, driven by premium rate adjustments across its medical lines and growth in its Medicare Advantage business. Despite increased medical costs impacting net income, which decreased by 26% to $2.5 billion, the company maintained a strong liquidity position and continued its share repurchase program. The company highlighted its significant market presence, serving 35 million members nationwide, and its diversified product offerings across commercial, consumer, and other segments. Strategic focus remains on organic growth, targeted acquisitions, and enhancing value-based care initiatives. The company's operational results were influenced by several key factors, including a 4% increase in benefit expenses primarily due to higher medical costs, and a 4% rise in selling, general, and administrative expenses, largely attributed to increased compensation and severance costs. However, these were partially offset by premium increases and growth in self-funded membership. The report also details the company's ongoing efforts in care management, technology integration, and quality initiatives, underscoring its commitment to improving healthcare value and member outcomes. The company's substantial investments in intangible assets, representing 46% of total assets, reflect its acquisitive growth strategy. Looking ahead, Elevance Health is positioned to navigate the evolving healthcare landscape by focusing on operational efficiency, strategic growth, and adapting to regulatory changes. The company's financial health remains solid, supported by a strong balance sheet and consistent operational cash flow, enabling continued investment in its business and return of capital to shareholders through its stock repurchase program. Investors should note the company's significant presence in both government-sponsored programs (Medicare and Medicaid) and commercial markets, offering a diversified revenue base.
Financial Highlights
51 data points| Revenue | $61.25B |
| Cost of Revenue | $468.50M |
| Gross Profit | $60.78B |
| SG&A Expenses | $8.50B |
| Operating Income | $4.35B |
| Interest Expense | $469.80M |
| Net Income | $2.49B |
| EPS (Basic) | $4.79 |
| EPS (Diluted) | $4.76 |
| Shares Outstanding (Basic) | 519.80M |
| Shares Outstanding (Diluted) | 523.00M |
Key Highlights
- 1Total operating revenue grew by 2% to $61.6 billion in 2008, driven by premium rate increases and Medicare Advantage growth.
- 2Net income decreased by 26% to $2.5 billion, impacted by higher medical costs and investment impairments.
- 3Medical membership reached 35 million, with growth in National and BlueCard segments partially offset by declines in State-Sponsored and Individual segments.
- 4The company repurchased approximately 56.4 million shares for $3.3 billion during 2008.
- 5Benefit expenses increased by 4% due to higher medical costs, leading to a higher benefit expense ratio of 83.6%.
- 6Selling, general, and administrative expenses increased by 4%, with a slight increase in the expense ratio to 14.6%.
- 7The company maintains a strong liquidity position with $17.4 billion in cash, cash equivalents, and investments as of December 31, 2008.